These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 21199916

  • 1. Patients with nonovarian peritoneal carcinomatosis achieve long-term survival.
    Barton MK.
    CA Cancer J Clin; 2011; 61(1):3-4. PubMed ID: 21199916
    [No Abstract] [Full Text] [Related]

  • 2. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M.
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [Abstract] [Full Text] [Related]

  • 3. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
    Gilly FN, Beaujard A, Glehen O, Grandclement E, Caillot JL, Francois Y, Sadeghi-Looyeh B, Gueugniaud PY, Garbit F, Benoit M, Bienvenu J, Vignal J.
    Anticancer Res; 1999 Oct; 19(3B):2317-21. PubMed ID: 10472351
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH, Rasmussen PC, Laurberg S.
    Ugeskr Laeger; 2007 Sep 17; 169(38):3179-81. PubMed ID: 17910824
    [Abstract] [Full Text] [Related]

  • 9. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
    Bartlett DL, Buell JF, Libutti SK, Reed E, Lee KB, Figg WD, Venzon DJ, Alexander HR.
    Cancer; 1998 Sep 15; 83(6):1251-61. PubMed ID: 9740093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of peritoneal carcinomatosis of unknown primary tumor site.
    Muggia FM, Baranda J.
    Semin Oncol; 1993 Jun 15; 20(3):268-72. PubMed ID: 8503022
    [No Abstract] [Full Text] [Related]

  • 12. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD, Chu F, Links M, Kam PC, Glenn D, Morris DL.
    Eur J Surg Oncol; 2006 Dec 15; 32(10):1119-24. PubMed ID: 16887321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E, Greenberg R, Avital S, Skornick Y, Schneebaum S.
    Isr Med Assoc J; 2007 Nov 15; 9(11):787-90. PubMed ID: 18085034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis.
    De Simone M, Barone R, Vaira M, Aghemo B, Mioli P, Franco C, Scuderi S, Costamagna D, Dei Poli M.
    J Surg Oncol; 2003 Feb 15; 82(2):138-40. PubMed ID: 12561072
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.